Phil Beales

Company: Axovia Therapeutics

Job title: CEO

Seminars:

Navigating Preclinical to Clinical Translation of AXV-101 to Accelerate Gene Therapy Development 2:30 pm

Selecting optimal animal models and securing regulatory approval to establish robust preclinical foundations across FDA and MHRA requirements Conducting dose-ranging studies achieving therapeutic windows comparable to other therapies to ensure safe and effective human translation Overcoming mouse-to-human dosing challenges and regulatory hurdles to successfully initiate clinical trials with promising early safety dataRead more

day: Conference Day One